These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1002 related articles for article (PubMed ID: 21271373)

  • 41. A cost analysis of screening methodology for family members of colorectal cancer patients.
    Rozen P; Ron E
    Am J Gastroenterol; 1989 Dec; 84(12):1548-51. PubMed ID: 2512809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of various strategies for colorectal cancer screening tests.
    Wohl P; Bednařík M; Wohl P; Cervenka M; Spičák J
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1157-64. PubMed ID: 21989120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
    Nash GF
    Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
    [No Abstract]   [Full Text] [Related]  

  • 45. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colorectal cancer screening in Europe: compliance and the choice of test.
    Riemann JF
    Endoscopy; 2010 Jul; 42(7):576-7. PubMed ID: 20593335
    [No Abstract]   [Full Text] [Related]  

  • 48. Colorectal carcinoma: is screening possible?
    Bonelli L
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():68-73. PubMed ID: 23018010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Implementation of colorectal cancer screening in Sweden].
    Thorlacius H; Toth E
    Lakartidningen; 2018 May; 115():. PubMed ID: 29809270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial colorectal cancer screening: When and what to do?
    Del Vecchio Blanco G; Paoluzi OA; Sileri P; Rossi P; Sica G; Pallone F
    World J Gastroenterol; 2015 Jul; 21(26):7944-53. PubMed ID: 26185367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of immunofecal occult blood test on colorectal cancer screening].
    Yang HY; Ge ZZ; Dai J; Li XB; Gao YJ
    Zhonghua Nei Ke Za Zhi; 2008 Aug; 47(8):642-5. PubMed ID: 19080296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Executive summary.
    von Karsa L; Patnick J; Segnan N
    Endoscopy; 2012 Sep; 44 Suppl 3():SE1-8. PubMed ID: 23012113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A questionnaire-based survey on screening for gastric and colorectal cancer by physicians in East Asian countries in 2010.
    Naito Y; Uchiyama K; Kinoshita Y; Fukudo S; Joh T; Suzuki H; Takahashi S; Ueno F; Fujiwara Y; Arakawa T; Matsumoto T; Hahm KB; Kachintorn U; Syam AF; Rani AA; Sollano JD; Zhu Q
    Digestion; 2012; 86(2):94-106. PubMed ID: 22846219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Colorectal cancer screening: situation and prospect].
    Guo C; Liu Q; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 May; 49(5):377-80. PubMed ID: 26081698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening and surveillance for colorectal cancer: state of the art.
    Kahi CJ; Anderson JC; Rex DK
    Gastrointest Endosc; 2013 Mar; 77(3):335-50. PubMed ID: 23410695
    [No Abstract]   [Full Text] [Related]  

  • 58. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
    Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
    [No Abstract]   [Full Text] [Related]  

  • 59. First six years of implementing colorectal cancer screening in the Osijek-Baranja County, Croatia--can we do better?
    Samardzić S; Mihaljević S; Dmitrović B; Milas J; Puntarić D; Tadijan D; Jelić K
    Coll Antropol; 2013 Sep; 37(3):913-8. PubMed ID: 24308237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colorectal cancers detected through screening are associated with lower stages and improved survival.
    Lindebjerg J; Osler M; Bisgaard C
    Dan Med J; 2014 Jan; 61(1):A4758. PubMed ID: 24393588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.